WAY-606954 is primarily used in scientific research as a selective agonist for the GPR119 receptor, which is involved in glucose homeostasis and insulin secretion. Its main application lies in the study of metabolic disorders, particularly type 2 diabetes. By activating GPR119, WAY-606954 helps researchers investigate pathways that regulate incretin hormone release, such as GLP-1, offering insights into potential therapeutic targets for enhancing glucose-dependent insulin release. It is also utilized in preclinical studies to evaluate the effects of sustained GPR119 activation on food intake, body weight, and lipid metabolism, supporting the development of new antidiabetic and anti-obesity drugs. Due to its research-specific nature, it is not used clinically or in industrial applications.